Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
Matt D.T. Hitchings, Otavio T. Ranzani, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Maria Almiron, Rodrigo Said, Ryan Borg, Wade L. Schulz, Roberto Dias de Oliveira, Patricia Vieira da Silva, Daniel Barros de Castro, Vanderson de Souza Sampaio, Bernardino Cláudio de Albuquerque, Tatyana Costa Amorim Ramos, Shadia Hussami Hauache Fraxe, Cristiano Fernandes da Costa, Felipe Gomes Naveca, Andre M. Siqueira, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
doi: https://doi.org/10.1101/2021.04.07.21255081
Matt D.T. Hitchings
1Department of Biology, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Otavio T. Ranzani
3Universidade de Sao Paulo, São Paulo, SP, Brazil
4Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
Mario Sergio Scaramuzzini Torres
5Municipal Health Secretary of Manaus
Silvano Barbosa de Oliveira
6Pan American Health Organization
Maria Almiron
6Pan American Health Organization
Rodrigo Said
6Pan American Health Organization
Ryan Borg
7Universidade de Brasília, Brasília, DF, Brazil
8Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Wade L. Schulz
9Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
10Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
Roberto Dias de Oliveira
11State University of Mato Grosso do Sul - UEMS, Dourados, MS, Brazil
Patricia Vieira da Silva
12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
Daniel Barros de Castro
13Fundação de Vigilância em Saúde do Estado do Amazonas
Vanderson de Souza Sampaio
13Fundação de Vigilância em Saúde do Estado do Amazonas
Bernardino Cláudio de Albuquerque
13Fundação de Vigilância em Saúde do Estado do Amazonas
Tatyana Costa Amorim Ramos
13Fundação de Vigilância em Saúde do Estado do Amazonas
Shadia Hussami Hauache Fraxe
15Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
Cristiano Fernandes da Costa
13Fundação de Vigilância em Saúde do Estado do Amazonas
Felipe Gomes Naveca
17Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
Andre M. Siqueira
Wildo Navegantes de Araújo
14Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, RS, Brazil
Jason R. Andrews
15Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
Derek A.T. Cummings
1Department of Biology, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Albert I. Ko
Julio Croda
9Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
17Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
Article usage
Posted April 07, 2021.
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
Matt D.T. Hitchings, Otavio T. Ranzani, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Maria Almiron, Rodrigo Said, Ryan Borg, Wade L. Schulz, Roberto Dias de Oliveira, Patricia Vieira da Silva, Daniel Barros de Castro, Vanderson de Souza Sampaio, Bernardino Cláudio de Albuquerque, Tatyana Costa Amorim Ramos, Shadia Hussami Hauache Fraxe, Cristiano Fernandes da Costa, Felipe Gomes Naveca, Andre M. Siqueira, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
medRxiv 2021.04.07.21255081; doi: https://doi.org/10.1101/2021.04.07.21255081
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
Matt D.T. Hitchings, Otavio T. Ranzani, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Maria Almiron, Rodrigo Said, Ryan Borg, Wade L. Schulz, Roberto Dias de Oliveira, Patricia Vieira da Silva, Daniel Barros de Castro, Vanderson de Souza Sampaio, Bernardino Cláudio de Albuquerque, Tatyana Costa Amorim Ramos, Shadia Hussami Hauache Fraxe, Cristiano Fernandes da Costa, Felipe Gomes Naveca, Andre M. Siqueira, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
medRxiv 2021.04.07.21255081; doi: https://doi.org/10.1101/2021.04.07.21255081
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12630)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (411)
- Health Economics (717)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2230)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)